Epstein Secrets

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadership

g the nation's opioid epidemic', with Purdue Pharma President and CEO Craig Landau and Sackler family members Dr Richard Sackler, David Sackler, Dr Kathe Sackler, and Mortimer Sackler having been invited to testify * The company and some members of the family have faced lawsuits over their role in encouraging

ey believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek <https://www.newsweek.com/reports-al-qaedas-demise-are-greatly-exagge

ng the nation's opioid epidemic', with Purdue Pharma President and CEO Craig Landau and Sackler family members Dr Richard Sackler, David Sackler, Dr Kathe Sackler, and Mortimer Sackler having been invited to testify * The company and some members of the family have faced lawsuits over their role in encouragin

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadershi

g the nation's opioid epidemic', with Purdue Pharma President and CEO Craig Landau and Sackler family members Dr Richard Sackler, David Sackler, Dr Kathe Sackler, and Mortimer Sackler having been invited to testify * The company and some members of the family have faced lawsuits over their role in encouragin